The Clinical Significance of Hyperoxalaemia

Bednar B. , Jirasek A. , Stejskal J. , Chytil M. Die sekundäre urämische oxalose. Zentralbl Allg Pathol 1961; 201: 289–97.

Bennett B. , Rosenblum C. Identification of calcium oxalate crystals in the myocardium of patients with uremia. Lab Invest 1961; 10: 947–55.

Lewis R.D. , Lowenstam H.A. , Rossman G.R. Oxalate nephrosis and crystalline myocarditis. Arch Pathol 1974; 98: 149–55.

Salyer W.R. , Keren D. Oxalosis as a complication of chronic renal failure. Kidney Int 1973; 4: 61–6.

Salyer W.R. , Hucthins G.M. Cardiac lesions in secondary oxalosis. Arch Intern Med 1974; 134: 250–2.

Fayemi A.O. , Ali M. , Braun E.V. Oxalosis in hemodialysis patients. Arch Pathol Lab Med 1979; 103: 58–62.

O'Callaghan J.W. , Arbuckle S.M. , Craswell P.W. , Boyle P.B. , Searle J.W. , Smythe W.R. Rapid progression of oxalosisinduced cardiomyopathy despite adequate haemodialysis. Mineral Electrolyte Metab 1984; 10: 48–51.

Op de Hoek C.T. , Diderich PPNM , Gratama S. , WeijsvHofwegen E.J.M. Oxalosis in chronic renal failure. Proc Eur Dial Transplant Assoc 1980; 17: 730–5.

Ishida K. , Yamanaka N. Oxalosis in chronic renal failure or chronic dialysis or both. Nippon Hinyokika Gakkai Zasshi 1980; 17: 1423–31.

Zarembski P.M. , Hodgkinson A. , Parsons F.M. Elevation of the concentration of plasma oxalic acid in renal failure. Nature 1966; 212: 511–2.

Constable A.R. , Joekes A.M. , Kasidas G.P. , O'Regan P. , Rose G.A. Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both. Clin Sci 1979; 56: 299–304.

O'Regan P.F.B. , Constable A.R. , Harrison A.R. , Joekes A.M. , Kasidas G.P. , Rose G.A. The management of the primary hyperoxaluric patient. In: Rose G.A. , Robertson W.E. , Watts R.W.E. , eds. Oxalate in human biochemistry and clinical pathology. London: Wellcome Trust 1979; 202–19.

Watts R.W.E. , Veall N. , Purkiss P. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure. Clin Sci 1984; 66: 591–7.

Watts R.W.E. , Calne R.Y. , Williams R. Primary hyperoxaluria (Type 1): attempted treatment by combined hepatic and renal transplantation. Quart J Med 1985; 57: 697–703.

Watts R.W.E. , Calne R.Y. , Rolles K. Successful treatment of primary hyperoxaluria type 1 by combined hepatic and renal transplantation. Lancet 1987; ii: 474–5.

Wolthers B.G. , Meijer S. , Tepper T. , Hayer M. , Elzinga H. The determination of oxalate in haemodialysate and plasma: a means to detect and study ‘hyperoxaluria’ in haemodialysed patients. Clin Sci 1986; 71: 41–7.

Boer P. , van Leersum L. , Hene R.J. , Dorhout Mees E.J. Plasma oxalate concentration in chronic renal disease. Am J Kidney Dis 1984; 4: 118–22.

Fituri N. , Keogh B. , Costello J. Effectiveness of hemodialysis and continuous ambulatory peritoneal dialysis in controlling plasma oxalate concentrations. Urol Res 1984; 12: 43–4.

Parkinson I.S. , Kealey T. , Laker M.F. The determination of plasma oxalate concentrations using an enzyme/bioluminescent assay. Clin Chim Acta 1985; 152: 335–45.

Tomson C.R.V. , Chanon S.M. , Parkinson I.S. , Simpson J.M. , Ward M.K. , Laker M.F. Determinants of plasma oxalate in patients on continuous ambulatory peritoneal dialysis. Clin Sci 1987; 73(Suppl 17): 27p–28p.

Yamauchi A. , Fujii M. , Shirai D. Plasma oxalate concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1986; 25: 181–5.

Worcester E.M. , Nakagawa Y. , Bushinsky D.A. , Coe F.L. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 1986; 77: 1888–96.

Robertson W.G. , Heyburn P.J. , Peacock M. , Hanes F.A. , Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci 1979; 57: 285–8.

Barsotti G. , Cristofano C. , Morelli E. , Meola M. , Lupetti S. , Giovanetti S. Serum oxalic acid in uremia: effect of a low-protein diet supplemented with essential amino acids and ketoanalogues. Nephron 1984; 38: 54–6.

Gonella M. , Vagelli G. , Lupetti S. , Calabrese G. , Pratesti G. Effect of CaCO₃ supplements on serum oxalate in patients on regular hemodialysis treatment. Proc Eur Dial Transplant Assoc 1985; 22: 93–6.

Pru C. , Eaton J. , Kjellstrand C. Vitamin C intoxication and hyperoxalaemia in chronic hemodialysis patients. Nephron 1985; 39: 112–6.

Balcke P. , Zazgornik J. , Schmidt P. , Kopsa H. , Haubenstock A. High dose vitamin C administration is harmful in patients on regular dialysis therapy. Proc Eur Dial Transplant Assoc 1985; 22: 147–51.

Ono K. , Hisaue Y. , Morimatsu M. Should vitamin C supplementation be restricted in regular hemodialysis patients? Trans Am Soc Artif Intern Organs 1986; 32: 111–3.

Swartz R.D. , Wesley J.R. , Sommermeyer M.G. , Lau K. Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition. Ann Intern Med 1984; 100: 530–1.

Friedman A.L. , Chesney R.W. , Gilbert E.F. , Gilchrist K.W. , Latorraca R. , Segar W.E. Secondary oxalosis as a complication of parenteral alimentation in acute renal failure. Am J Nephrol 1983; 3: 248–52.

Watts R.W.E. , Veall N. , Purkiss P. , Mansell M.A. , Haywood E.F. The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (with glycolic aciduria). Clin Sci 1985; 69: 87–90.

Balcke P. , Schmidt P. , Zazgonik J. , Kopsa H. , Deutsch E. Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients. Eur J Clin Invest 1982; 12: 481–3.

Morgan S.H. , Purkiss P. , Maher E.R. , Watts R.W.E. , Curtis J.R. Oxalate retention in end-stage renal failure: haemodialysis vs chronic ambulatory peritoneal dialysis and the effects of ascorbic acid and pyridoxine. Clin Sci 1987; 73(Suppl 17): 41p.

Farooqui S. , Nath R. , Thind S.K. , Mahmood A. Effect of pyridoxine deficiency on intestinal absorption of calcium and oxalate: chemical composition of brush border membranes in rats. Biochemical Med 1984; 32: 34–42.

Richter M.N. , Richter K.S. Anisotropic crystals in the human thyroid gland. Am J Path 1954; 30: 545–53.

Zimmerman L.A. , Johnson F.B. Calcium oxalate crystals within ocular tissues. Arch Ophth 1958; 60: 372–83.

Glynn L.E. Crystalline bodies in the tunica media of a middle cerebral artery. J Path Bact 1940; 51: 445–6.

Jacobs C. , Rottembourg J. , Reach I. , Legrain M. Terminal renal failure due to oxalosis in 14 patients. Proc Eur Dial Transplant Assoc 1975; 11: 359–65.

Arbus G.S. , Sniderman S. Oxalosis with peripheral gangrene. Arch Pathol 1974; 97: 107–10.

Dunnill M.S. , Millard P.R. , Oliver D. Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Path 1977; 30: 868–77.

Oren A. , Husdan H. , Cheng P.T. Calcium oxalate kidney stones in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25: 534–8.

Milgram J.W. , Salyer W.R. Secondary oxalosis of bone in chronic renal failure. J Bone Joint Surg 1974; 56A: 387–95.

Ott S.M. , Andress D.L. , Sherrard D.J. Bone oxalate in a longterm hemodialysis patient who ingested high doses of vitamin C. Am J Kidney Dis 1986; 8: 450–4.

Hoffman G.S. , Schumacher H.R. , Paul H. Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med 1982; 97: 36–42.

Platt P.N. , Salahuddin M. , Dick W.C. Articular problems in renal dialysis patients. Eur J Clin Invest 1986; 16: 25.

Reed G.H. , Morgan S.D. Kinetic and magnetic resonance studies of the interaction of oxalate with pyruvate kinase. Biochemistry 1974; 13: 3537–41.

Buc H. , Demaugre F. , Leroux J.P. The kinetic effects of oxalate on liver and erythrocyte pyruvate kinases. Biochem Biophys Res Commun 1978; 85: 774–9.

Yount E.A. , Harris R.A. Studies on the inhibition of gluconeogenesis by oxalate. Biochim Biophys Acta 1980; 633: 122–33.

Emerson P.M. , Wilkinson J.H. Urea and oxalate inhibition of the serum lactate dehydrogenase. J Clin Path 1965; 18: 803–7.

Wilkinson J.H. , Fujimoto Y. , Senesly D. , Ludwig G.D. Nature of the inhibitors of lactate dehydrogenase in uremic dialysates. J Lab Clin Med 1970; 75: 109–19.

Beutler E. , Forman L. , West C. Effect of oxalate and malonate on red cell metabolism. Blood 1987; 70: 1389–93.